Potential barriers to the use of anti‐obesity medications in persons with spinal cord injuries and disorders
There are several potential barriers to AOM use in the SCI/D population. Barriers include AOM side effects which may cause or exacerbate conditions that are already concerns in persons with SCI/D, such as bowel and skin problems, and muscle loss. SCI/D HCPs reported a lack of evidence about AOM use in persons with SCI/D, but interest in obtaining more knowledge.
Authors
- Sherri L. LaVela (ORCID: https://orcid.org/0000-0001-9900-0120)
- Lorena Reyes (ORCID: https://orcid.org/0009-0004-1635-349X)
- Dan Eisenberg (ORCID: https://orcid.org/0000-0002-5908-3942)
- Gary J. Farkas (ORCID: https://orcid.org/0000-0002-5482-6049)
- Ibuola Kale (ORCID: https://orcid.org/0000-0002-0672-3328)
- Kelsey Berryman (ORCID: https://orcid.org/0000-0002-5553-067X)
- Geoffrey Henderson (ORCID: https://orcid.org/0000-0003-3596-3192)
- Vanessa Rosales
Institutions
- Northwestern University (US)
- University of Miami (US)
- SUNY Upstate Medical University (US)
- VA Palo Alto Health Care System (US)
- Edward Hines, Jr. VA Hospital (US)
- Stanford Medicine (US)
- Center for Innovation (US)
Publication Details
- Journal
- Obesity Science & Practice
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1002/osp4.784
- Citations
- 2
- Primary Topic
- Spinal Cord Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- U.S. Department of Veterans Affairs
- Health Services Research and Development